Estimating the health impact and cost-effectiveness of emergency department opt-out testing for blood-borne viruses in Germany

In Germany, an estimated 8,200 individuals were living with undiagnosed HIV in 2023. Late diagnosis (CD4<350) was 52% and 33% of individuals with HIV are diagnosed with advanced disease (1) . Despite progress toward the WHO viral hepatitis elimination goals, a large proportion of infections remain undiagnosed: 85% for hepatitis B (HBV) and 60% for Read More >
CROI Conference 2026: New modelling study examines whether Scotland and Ireland are on track to eliminate HIV transmission

Aquarius Population Health presented new modelling research at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 in Denver, Colorado, February 22-25, examining whether Scotland and Ireland are on course to eliminate new HIV transmissions by 2030. Both countries have committed to meeting the UNAIDS target of fewer than one new infection acquired within the country Read More >
Advancing elimination targets for viral hepatitis and HIV in Poland: estimating the cost-effectiveness of emergency department opt-out testing for blood-borne viruses

Poland continues to face challenges in meeting viral hepatitis and HIV elimination goals. Diagnosis rates for hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV remain below elimination targets, while delayed diagnosis and gaps in linkage to care contribute to poorer health outcomes. Since 2022, forced migration from Ukraine has increased the number of people Read More >
Estimating the number of individuals who need to receive PrEP to meet England’s 2030 HIV transmission elimination goals

England has committed to eliminating HIV transmission by 20301. Although significant progress has been made in reducing new HIV diagnoses, existing evidence suggests increased investment in prevention efforts is required to meet the elimination target2,3. Pre-exposure prophylaxis (PrEP) is widely available through sexual health services in England: In 2024, 111,000 individuals accessed PrEP in sexual Read More >
When will the UK achieve HIV transmission elimination? Modelling the impact of current HIV prevention efforts on progress towards the 2030 elimination goal

In 2019, the previous UK government set the ambitious target of eliminating HIV transmission within the UK by 2030. While great progress has been made in HIV prevention and treatment in the UK, with England reaching the UNAIDS 95-95-95 target in 20231, past evidence suggested that the goal of ‘elimination’ by 2030 is unlikely to Read More >
An Implementation Tool For US Professionals: First Void Urine Self-Sampling for Primary HPV Cervical Cancer Screening

The national coverage of cervical cancer screening in the US is falling, with about 1 in 4 women not up to date with screening1. Under-screened women bear the greatest burden of disease. Evidence shows 60-64% of American women diagnosed with cervical cancer were unscreened, highlighting the need to explore alternative methods to improve access2-4. In Read More >
Mapping and comparing COPD Care Pathways across 10 countries to understand barriers to optimal care: clinicians’ perspectives
Care Pathway Mapping for Dravet Syndrome (DS) Patients in England
Analysing the COPD care pathway in Japan, Canada, England, and Germany: a global view
A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting